NASDAQ

CytomX Therapeutics, Inc. (CTMX)

♥ 575 Thanks from members

Live price chart, market sentiment, and community perspectives for CytomX Therapeutics, Inc. (NASDAQ: CTMX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dr. Patrick K. BurgessFounder: Dr. Robert S. LowmanLeadership: Sean McCarthy (CEO)Holder: FMR LLCHolder: BlackRock Inc.Holder: Vanguard Group Inc.Pankoomab-gatipotuzumabCX-2009Probody Platform#CTMX#CytomX Therapeutics#Probody#Biotech Stock#Cancer Therapeutics